Federico Ricci

6PUBLICATIONS
37CO-AUTHORS
Optical technologyVision sciencePredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 06, 2026
Switching to aflibercept 8 mg in neovascular age-related macular degeneration: real-world outcomes according to switch indication.

|Oct 25, 2024
Longitudinal Structural and Functional Evaluation of Dark-without-Pressure Fundus Lesions in Patients with Autoimmune Diseases.

Marco Lombardo, Federico Ricci, Andrea Cusumano

|Oct 23, 2023
Twenty-four-month real-life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in Caucasians.

Matteo Airaldi, Alessandro Invernizzi, Vuong Nguyen

|Nov 20, 2021
Epigenomic signatures in age-related macular degeneration: Focus on their role as disease modifiers and therapeutic targets.

Valerio Caputo, Claudia Strafella, Andrea Termine

|Nov 06, 2020
Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches.

Federico Ricci, Francesco Bandello, Pierluigi Navarra

Pageof 1